结直肠肝转移的实际处理。

IF 1.3 Q3 Medicine Minerva chirurgica Pub Date : 2020-10-01 Epub Date: 2020-08-06 DOI:10.23736/S0026-4733.20.08436-9

Leticia Pérez-Santiago, Dimitri Dorcaratto, Marina Garcés-Albir, Elena Muñoz-Forner, Marisol Huerta Álvaro, Susana Roselló Keranën, Luis Sabater

{"title":"结直肠肝转移的实际处理。","authors":"Leticia Pérez-Santiago, Dimitri Dorcaratto, Marina Garcés-Albir, Elena Muñoz-Forner, Marisol Huerta Álvaro, Susana Roselló Keranën, Luis Sabater","doi":"10.23736/S0026-4733.20.08436-9","DOIUrl":null,"url":null,"abstract":"Colorectal cancer is one of the most frequent cancers in the world and between 50% and 60% of patients will develop colorectal liver metastases (CRLM) during the disease. There have been great improvements in the management of CRLM during the last decades. The combination of modern chemotherapeutic and biological systemic treatments with aggressive surgical resection strategies is currently the base for the treatment of patients considered unresectable until few years ago. Furthermore, several new treatments for the local control of CRLM have been developed and are now part of the arsenal of multidisciplinary teams for the treatment of these complex patients. The aim of this review was to summarize and update the management of CRLM, its controversies and relevant evidence.","PeriodicalId":18714,"journal":{"name":"Minerva chirurgica","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The actual management of colorectal liver metastases.\",\"authors\":\"Leticia Pérez-Santiago, Dimitri Dorcaratto, Marina Garcés-Albir, Elena Muñoz-Forner, Marisol Huerta Álvaro, Susana Roselló Keranën, Luis Sabater\",\"doi\":\"10.23736/S0026-4733.20.08436-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Colorectal cancer is one of the most frequent cancers in the world and between 50% and 60% of patients will develop colorectal liver metastases (CRLM) during the disease. There have been great improvements in the management of CRLM during the last decades. The combination of modern chemotherapeutic and biological systemic treatments with aggressive surgical resection strategies is currently the base for the treatment of patients considered unresectable until few years ago. Furthermore, several new treatments for the local control of CRLM have been developed and are now part of the arsenal of multidisciplinary teams for the treatment of these complex patients. The aim of this review was to summarize and update the management of CRLM, its controversies and relevant evidence.\",\"PeriodicalId\":18714,\"journal\":{\"name\":\"Minerva chirurgica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2020-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva chirurgica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23736/S0026-4733.20.08436-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/8/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva chirurgica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0026-4733.20.08436-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/8/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

结直肠癌是世界上最常见的癌症之一，50%至60%的患者在发病期间会发生结直肠癌肝转移(CRLM)。在过去的几十年里，CRLM的管理有了很大的改进。现代化疗和生物系统治疗与积极的手术切除策略相结合，目前是治疗几年前被认为不可切除的患者的基础。此外，已经开发了几种局部控制CRLM的新治疗方法，现在已成为治疗这些复杂患者的多学科团队的一部分。本综述的目的是总结和更新CRLM的管理，其争议和相关证据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The actual management of colorectal liver metastases.

Colorectal cancer is one of the most frequent cancers in the world and between 50% and 60% of patients will develop colorectal liver metastases (CRLM) during the disease. There have been great improvements in the management of CRLM during the last decades. The combination of modern chemotherapeutic and biological systemic treatments with aggressive surgical resection strategies is currently the base for the treatment of patients considered unresectable until few years ago. Furthermore, several new treatments for the local control of CRLM have been developed and are now part of the arsenal of multidisciplinary teams for the treatment of these complex patients. The aim of this review was to summarize and update the management of CRLM, its controversies and relevant evidence.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Minerva chirurgica 医学-外科

CiteScore

1.40

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Minerva Chirurgica publishes scientific papers on surgery. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, special articles, letters to the Editor and guidelines. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work.